EUVIMEDEUVIMED entdecken
Crossref

An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis

Xinyi Liao, Junhong Chen, Yunzhu Wan, Wenfei Xu, Jianhua Zhou iD, Yanping Liu, Xuhui Li, Chongguang Yang, Jiasi Wang iD

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c02379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xinyi Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen …. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Isoniazid, Bacterial Proteins, Drug Resistance, Bacterial. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-resistance Tuberculosis (TB) is a major threat to global public health. Simple and precise detection of the mutations associated with drug resistance is still a significant challenge. CRISPR-based nucleic acid detection has emerged as a transformative technology in molecular diagnostics due to its high specificity and programmability. However, the CRISPR-Cas12a system requires a protospacer adjacent motif (PAM) in the target double-stranded DNA (dsDNA) for efficient recognition and activation, which limits its application for detecting single-nucleotide variants (SNVs). To overcome this limitation, we leveraged high-affinity xenonucleic acids (XNAs) to engineer an XNA-CRISPR platform that combines a helicase and sequence-specific XNAs (such as peptide nucleic acid (PNA), locked nucleic acid (LNA), or 2′-modified RNA), to unwind the dsDNA, enabling them to invade and form stable hybrids, thereby displacing a single strand for PAM-independent Cas12a activation. This recognition mechanism, combining XNA hybridization and CRISPR verification, achieves single-base resolution. To bridge the sensitivity gap for clinical application, we integrated this platform with polydisperse droplet digital technology (PddXNA-CRISPR), which significantly enhanced the sensitivity. Clinical sputum samples were detected by using PddXNA-CRISPR for Mycobacterium tuberculosis (MTB) katG Ser315Thr mutation, which showed 90% concordance with sequencing results. This modular, amplification-free platform expands the CRISPR-based diagnostic toolkit and provides a versatile and sensitive approach for detecting critical SNVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisIsoniazidBacterial ProteinsDrug Resistance, BacterialCatalaseAntitubercular AgentsCRISPR-Cas SystemsMutationHumans

Substanzen

IsoniazidBacterial ProteinskatG protein, Mycobacterium tuberculosisCatalaseAntitubercular Agents

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen518107, China.
  • School of Public Health (Shenzhen), Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Guangdong518107, China.
  • Zhejiang Key Laboratory of Multiomics and Molecular Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, Zhejiang314006, China.

ORCID-Profile: Jianhua Zhou, Jiasi Wang

Förderung

  • Science and Technology Foundation of Shenzhen City
  • Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • National Key Research and Development Program of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Medical Research Fund
  • China Resources Research Institute of Science & Technology

Zitieren

APA

Liao, X., Chen, J., Wan, Y., Xu, W., Zhou, J., Liu, Y., Li, X., Yang, C., & Wang, J. (2026). An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02379

Vancouver

Liao X, Chen J, Wan Y, Xu W, Zhou J, Liu Y, et al. An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02379

BibTeX
@article{Liao2026,
  author = {Liao, Xinyi and Chen, Junhong and Wan, Yunzhu and Xu, Wenfei and Zhou, Jianhua and Liu, Yanping and Li, Xuhui and Yang, Chongguang and Wang, Jiasi},
  title = {An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c02379}
}
Kostenlos starten →